For example, NPM1, the most commonly mutated gene in AML, is mutated in only 28% of AML and many genes are recurrently mutated, but in less than 10% of patients, for example, ASXL1, IDH2, RUNX1, and SRSF22,3. Here, IDH2 is linked to acute myeloid leukemia.